[Assessment of secondary disease based on HLA expression in the plasma of an allogeneic bone marrow recipient].
Zotnikov Ea, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Golovkina Ll, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Vasil'eva Mn, Poreshina Lp, Kut'ina Rm, Liubimov Ls
PubMed
December 1, 1995
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59